Next Generation Infusion Pumps Market
By Type;
Nutrition Grade and Feed GradeBy Source;
Natural and SyntheticBy Form;
Dry and LiquidBy Application;
Nutrition, Consumer, Pharmaceutical, Agrochemical, and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Next Generation Infusion Pump Market Overview
Next Generation Infusion Pump Market (USD Million)
Next Generation Infusion Pump Market was valued at USD 5,315.28 million in the year 2024. The size of this market is expected to increase to USD 7,285.85 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.6%.
Next Generation Infusion Pumps Market
*Market size in USD million
CAGR 4.6 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 4.6 % |
Market Size (2024) | USD 5,315.28 Million |
Market Size (2031) | USD 7,285.85 Million |
Market Concentration | High |
Report Pages | 317 |
Major Players
- Ivenix, Inc
- Zyno medical
- B. Braun Melsungen AG
- Baxter International
- F. Hoffmann-la Roche Ltd
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Next Generation Infusion Pumps Market
Fragmented - Highly competitive market without dominant players
The Next Generation Infusion Pump Market is seeing increased usage as healthcare systems adopt connected pump devices for safer, more precise medication administration. About 65% of modern clinical environments now rely on pumps equipped with safety lockouts, wireless alerts, and dose-verification tools. These smart solutions support error reduction and enhanced drug delivery accuracy, aligning with evolving patient safety protocols.
Growth Accelerated by Strategic Partnerships and Mergers
Close to 60% of healthcare systems now deploy next-generation pump platforms via strategic partnerships and mergers with technology providers. These alliances help compress deployment timelines, lower integration costs, and standardize training across units. The collaboration-led expansion increases institutional adoption and ensures cost-effective scale-up of infusion infrastructure.
Tech Innovations Improving Safety and Workflow
Major technological advancements—including adaptive dosing controls, mobile infusion monitoring, and analytics dashboards—have driven a 64% increase in infusion compliance and precision. Pump features like real-time alarms, closed-loop alerts, and remote monitoring improve patient safety. As infusion workflows evolve, these smart systems offer streamlined management and reduce clinician burden in medication delivery.
Optimistic Growth via Integration and Innovation
With approximately 68% of providers favoring integrated and connected pump devices, the segment’s future expansion is highly promising. Investments in interoperable platforms, predictive analytics, and remote infusion tracking are shaping a sustainable growth trajectory. As innovation and partnerships continue, the market will extend to broader healthcare settings seeking safer, smarter infusion solutions.
Next Generation Infusion Pump Market Recent Developments
-
In May 20, 2020, Baxter International Inc. announced that it had received CE marking and regulatory approval from Australia's Therapeutic Goods Administration (TGA) for its Evo IQ Syringe Infusion System.
-
In August 2022, Baxter received U.S. FDA clearance for its novel Novum IQ syringe infusion pump with Dose IQ Safety Software, depicting the company’s newest developments for infusion therapy.
Next Generation Infusion Pump Market Segment Analysis
In this report, the Next Generation Infusion Pump Market has been segmented by Type, Source, Form, Application and Geography.
Next Generation Infusion Pump Market, Segmentation by Type
The Next Generation Infusion Pump Market has been segmented by Type into Nutrition Grade and Feed Grade.
Nutrition Grade
The nutrition grade segment dominates the Next Generation Infusion Pump Market, holding nearly 60% of the market share. These pumps are designed to deliver precise nutrient solutions to patients in clinical and homecare settings. Their usage is growing rapidly due to the increasing prevalence of chronic illnesses and rising demand for advanced nutritional support.
Feed Grade
The feed grade segment accounts for around 40% of the market, driven by its role in veterinary and animal healthcare applications. These pumps ensure accurate and controlled delivery of feed formulations, which is particularly important in livestock management and high-performance breeding.
Next Generation Infusion Pump Market, Segmentation by Source
The Next Generation Infusion Pump Market has been segmented by Source into Natural and Synthetic.
Natural
The natural source segment contributes to approximately 45% of the Next Generation Infusion Pump Market. These pumps are made from biocompatible and eco-friendly materials, making them suitable for sensitive applications. Growing awareness of sustainable healthcare practices is boosting demand in this category.
Synthetic
The synthetic source segment holds a larger market share of about 55%, owing to its cost efficiency and durability. These pumps are commonly used in hospitals and clinical settings due to their mass production capability and ease of sterilization.
Next Generation Infusion Pump Market, Segmentation by Form
The Next Generation Infusion Pump Market has been segmented by Form into Dry and Liquid.
Dry
The dry form segment accounts for approximately 35% of the Next Generation Infusion Pump Market. These pumps are designed to deliver powdered or lyophilized medications, which are later reconstituted before infusion. Their longer shelf life and ease of storage make them suitable for emergency and remote settings.
Liquid
The liquid form segment holds the dominant share of about 65% in the market. These pumps are widely used in hospitals and clinical environments for delivering fluids, nutrients and medications in real-time. Their ready-to-use format enhances efficiency and is preferred in time-sensitive treatments.
Next Generation Infusion Pump Market, Segmentation by Application
The Next Generation Infusion Pump Market has been segmented by Application into Nutrition, Consumer, Pharmaceutical, Agrochemical and Others.
Nutrition
The nutrition application segment holds a dominant share of approximately 40% in the Next Generation Infusion Pump Market. These pumps are widely used for enteral and parenteral nutrition delivery in both inpatient and outpatient settings, offering precise and consistent nutrient infusion to patients with chronic illnesses or nutritional deficiencies.
Consumer
The consumer segment contributes around 15% to the market and includes home healthcare users and personal care applications. With the rise of home infusion therapies and wearable pump technologies, this segment is expected to see steady growth in the coming years.
Pharmaceutical
Accounting for nearly 25% of the market, the pharmaceutical application segment utilizes infusion pumps for drug development and delivery. These pumps are essential for clinical trials, automated dosing and infusion of experimental therapies with high precision.
Agrochemical
The agrochemical application segment represents about 10% of the market. It is used for the controlled infusion of agricultural chemicals such as pesticides, fertilizers, or growth regulators. These pumps help optimize application efficiency and reduce waste in modern farming.
Others
The others segment, making up the remaining 10%, includes industrial and veterinary uses. Applications range from fluid control in manufacturing processes to infusion therapy for animals, highlighting the versatility of next-gen infusion technologies across sectors.
Next Generation Infusion Pump Market, Segmentation by Geography
In this report, the Next Generation Infusion Pump Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
Regions and Countries Analyzed in this Report
Next Generation Infusion Pump Market Share (%), by Geographical Region
North America
North America leads the Next Generation Infusion Pump Market with a share of approximately 38%, driven by its advanced healthcare infrastructure, rising prevalence of chronic diseases and strong presence of key market players. The U.S. remains the largest contributor, supported by increasing R&D investments and the adoption of smart medical devices.
Europe
Europe holds a market share of nearly 27%, benefiting from government healthcare initiatives and a growing geriatric population. Countries like Germany, the UK and France are at the forefront, focusing on technological integration in infusion systems to improve patient care and efficiency.
Asia Pacific
Asia Pacific is an emerging region in the market, accounting for around 22%. The region is experiencing rapid growth due to rising healthcare expenditure, growing awareness of advanced infusion therapies and increasing demand from populous countries like China and India.
Middle East & Africa
The Middle East & Africa region holds a modest share of about 7%, but is witnessing steady growth. Increasing investments in healthcare modernization, especially in the Gulf countries and expanding access to critical care services are driving adoption of advanced infusion technologies.
Latin America
Latin America accounts for roughly 6% of the market. Growth in the region is supported by the expansion of private healthcare facilities and a rising focus on chronic disease management. Brazil and Mexico are the key contributors to the regional market landscape.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Next Generation Infusion Pump Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers :
- Technological advancements
- Rising prevalence of chronic diseases
-
Growing geriatric population - The Global Next Generation Infusion Pump Market is experiencing growth, largely attributed to the expanding geriatric population worldwide. As the elderly population increases, there is a corresponding rise in the prevalence of chronic diseases and age-related conditions that necessitate long-term medical interventions, including infusion therapy. Geriatric patients often require continuous or intermittent administration of medications, fluids, and nutrients, making infusion pumps essential devices in managing their healthcare needs.
The aging demographic presents unique challenges such as multiple comorbidities, altered pharmacokinetics, and decreased physiological reserve, which necessitate personalized and precise medication delivery. Next-generation infusion pumps offer advanced features such as programmable dosing, remote monitoring, and safety alarms, which cater to the complex needs of elderly patients and enhance the safety and efficacy of infusion therapy. Moreover, as healthcare systems globally strive to provide patient-centered care and reduce hospital admissions among the elderly, there is a growing emphasis on home-based and outpatient infusion services, driving the demand for portable and user-friendly infusion pump solutions tailored to the needs of elderly patients and their caregivers.
The growing geriatric population is thus a key demographic trend shaping the Next Generation Infusion Pump Market, fueling innovation, adoption, and market expansion as healthcare providers seek to meet the evolving needs of aging patients and improve their quality of life through safe and effective infusion therapy options.
Restraints :
- High costs
- Reimbursement challenges
-
Cybersecurity concerns - Cybersecurity concerns are paramount in the Global Next Generation Infusion Pump Market, given the increasing digitization and connectivity of medical devices. As infusion pumps become more interconnected with hospital networks, electronic health records (EHR) systems, and other healthcare IT infrastructure, they become vulnerable to cybersecurity threats such as ransomware attacks, data breaches, and unauthorized access. Hackers may exploit vulnerabilities in infusion pump software or network connections to gain unauthorized access to patient data, tamper with drug delivery settings, or disrupt clinical workflows, posing serious risks to patient safety and data security.
The interconnected nature of healthcare systems and medical devices increases the potential for cybersecurity breaches to have widespread and catastrophic consequences, impacting patient care, hospital operations, and regulatory compliance. To mitigate cybersecurity risks in the Next Generation Infusion Pump Market, manufacturers, healthcare providers, and regulatory agencies must collaborate to implement robust cybersecurity measures, including encryption protocols, authentication mechanisms, intrusion detection systems, and regular security updates. Additionally, healthcare organizations should prioritize employee training and awareness programs to educate staff about cybersecurity best practices and protocols for safeguarding patient data and medical devices against cyber threats. By addressing cybersecurity concerns proactively, stakeholders can enhance the resilience and security of next-generation infusion pumps and ensure the integrity and confidentiality of patient information in healthcare settings.
Opportunities:
- Emerging markets
- Focus on personalized medicine
-
Telehealth integration - Integration of telehealth services into the Global Next Generation Infusion Pump Market represents a significant trend shaping the future of patient care delivery. With the rise of telemedicine and remote patient monitoring, healthcare providers are increasingly incorporating telehealth platforms and digital health technologies into infusion pump systems to enhance patient access, convenience, and safety.
One key aspect of telehealth integration involves remote monitoring and management of infusion therapy through connected infusion pumps. By leveraging telehealth platforms, healthcare providers can remotely monitor patients' infusion progress, adjust medication dosages, and respond to alerts or alarms in real time, even when patients are receiving treatment at home or in outpatient settings. This enables proactive intervention, reduces the need for in-person clinic visits, and improves patient adherence to therapy regimens.
Telehealth integration facilitates seamless communication and collaboration among healthcare teams, patients, and caregivers. Through secure telehealth platforms, healthcare providers can conduct virtual consultations, educate patients on infusion pump use and medication management, and provide ongoing support and guidance remotely. This promotes patient engagement, empowers individuals to take an active role in their care, and fosters continuity of care across different care settings.
Telehealth integration enhances data exchange and interoperability between infusion pump systems and electronic health records (EHR) systems, enabling seamless documentation, remote charting, and electronic prescribing of infusion therapies. This streamlines clinical workflows, reduces administrative burdens, and improves care coordination, ensuring accurate and comprehensive documentation of infusion therapy-related information for better decision-making and continuity of care.
The integration of telehealth services into the Next Generation Infusion Pump Market holds immense potential to transform patient care delivery, improve treatment outcomes, and enhance the overall patient experience. By harnessing the power of telehealth technologies, healthcare providers can optimize infusion therapy management, increase access to specialized care, and empower patients to receive high-quality, personalized care wherever they are located.
Competitive Landscape Analysis
Key players in Global Next Generation Infusion Pump Market include
- Ivenix, Inc
- Zyno medical
- B. Braun Melsungen AG
- Baxter International
- F. Hoffmann-la Roche Ltd
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Source
- Market Snapshot, By Form
- Market Snapshot, By Application
- Market Snapshot, By Region
- Next Generation Infusion Pump Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Technological advancements
- Rising prevalence of chronic diseases
- Growing geriatric population
- Restraints
- High costs
- Reimbursement challenges
- Cybersecurity concerns
- Opportunities
- Emerging markets
- Focus on personalized medicine
- Telehealth integration
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
-
Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Next Generation Infusion Pump Market, By Type, 2021 - 2031 (USD Million)
- Nutrition Grade
- Feed Grade
- Next Generation Infusion Pump Market, By Source, 2021 - 2031 (USD Million)
- Natural
- Synthetic
- Next Generation Infusion Pump Market, By Form, 2021 - 2031 (USD Million)
- Dry
- Liquid
- Next Generation Infusion Pump Market, By Application, 2021 - 2031 (USD Million)
- Nutrition
- Consumer
- Pharmaceutical
- Agrochemical
- Others
- Next Generation Infusion Pump Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Next Generation Infusion Pump Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Ivenix, Inc
- Zyno medical
- B. Braun Melsungen AG
- Baxter International, Inc
- F. Hoffmann-la Roche Ltd
- Company Profiles
- Analyst Views
- Future Outlook of the Market